Financials
- Market Capitalization 151.1 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.59
ratio cours/chiffre d'affaires
34.34
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3737 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.62 USD | -1.59% | -1.59% | -35.42% | +50.30% | 150.94 M USD | ||
| 3738 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.14 USD | -0.87% | -0.87% | -13.64% | -40.00% | 151.90 M USD | ||
| 3749 | ADCT ADC Therapeutics SA Common Shares | 1.16 USD | -0.85% | +18.37% | +8.41% | -62.46% | 148.09 M USD | ||
| 3764 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.07 USD | -2.50% | -7.31% | +1.40% | -22.12% | 141.23 M USD |